I agree that this site is using cookies. You can find further informations here.
X
Carras, S.
60  results:
Search for persons X
?
1

Transfusion needs after CD19 CAR T‐cells for large B‐cell l..:

Vic, S. ; Thibert, J. ; Bachy, E....
Hematological Oncology.  41 (2023)  S2 - p. 534-536 , 2023
Link: https://doi.org/10.1002/..
 
?
2

PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER A..:

Sesques, P. ; Di blasi, R. ; Legouill, S....
Hematological Oncology.  41 (2023)  S2 - p. 202-204 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T..:

Marouf, A. ; Chaubard, S. ; Michot, J....
Hematological Oncology.  41 (2023)  S2 - p. 502-503 , 2023
Link: https://doi.org/10.1002/..
 
?
4

CHROMATIN ACCESSIBILITY PROFILING TO INCREASE DIAGNOSTIC AC..:

Julia, E. ; Mareschal, S. ; Chebel, A....
Hematological Oncology.  41 (2023)  S2 - p. 192-193 , 2023
Link: https://doi.org/10.1002/..
 
?
5

Long‐term analysis of the RiBVD phase II trial reveals the ..:

Carras, S. ; Torroja, A. ; Emadali, A....
Hematological Oncology.  41 (2023)  S2 - p. 481-483 , 2023
Link: https://doi.org/10.1002/..
 
?
6

KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF L..:

Cheminant, M. ; Carras, S. ; Bruneau, J....
Hematological Oncology.  41 (2023)  S2 - p. 838-839 , 2023
Link: https://doi.org/10.1002/..
 
?
7

S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-H..:

SESQUES, P. ; DI BLASI, R. ; LE GOUILL, S....
HemaSphere.  6 (2022)  - p. 111-112 , 2022
Link: https://doi.org/10.1097/..
 
?
8

S260: A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTA..:

Bachy, E. ; Le Gouill, S. ; Sesques, P....
HemaSphere.  6 (2022)  - p. 161-162 , 2022
Link: https://doi.org/10.1097/..
 
?
9

KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY..:

Cheminant, M. ; Decroos, A. ; Bruneau, J....
Hematological Oncology.  37 (2019)  S2 - p. 204-205 , 2019
Link: https://doi.org/10.1002/..
 
?
10

FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLIN..:

Gressin, R. ; Daguindau, N. ; Tempescul, A....
Hematological Oncology.  35 (2017)  S2 - p. 141-142 , 2017
Link: https://doi.org/10.1002/..
 
?
11

Allogeneic stem cell transplantation for patients with mant..:

Tessoulin, B ; Ceballos, P ; Chevallier, P...
Bone Marrow Transplantation.  51 (2016)  9 - p. 1184-1190 , 2016
Link: https://doi.org/10.1038/..
 
?
12

First-line treatment of double- and triple-hit lymphomas: S..:

Laude, M. C ; Lebras, L ; Sesques, P...
10.1002/ajh.26068.  , 2023
Link: https://hdl.handle.net/2..
 
?
13

KIR3DL2 may represent a novel therapeutic target in aggress..:

Decroos, A ; Cheminant, M ; Bruneau, J...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2022.282220.  , 2023
Link: https://serval.unil.ch/n..
 
?
14

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
10.1038/s41591-022-01969-y.  , 2023
Link: https://hdl.handle.net/2..
 
?
15

A real-world comparison of tisagenlecleucel and axicabtagen..:

Bachy, E ; Le Gouill, S ; Di Blasi, R...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41591-022-01969-y.  , 2022
Link: https://hal.univ-lille.f..
 
1-15